Loading...
•
Mar 31, 2025
Teladoc Q1 2025 Earnings Report
Reported financial results for the three months ended March 31, 2025
Key Takeaways
Teladoc Health reported a decrease in revenue and adjusted EBITDA in the first quarter of 2025 compared to the prior year. Revenue decreased 3% to $629.4 million, and adjusted EBITDA decreased 8% to $58.1 million. The company also reported a net loss of $93.0 million. Integrated Care segment revenue increased, while BetterHelp segment revenue decreased. The company completed the acquisition of UpLift Health Technologies during the quarter.
Revenue decreased 3% to $629.4 million in Q1 2025 compared to Q1 2024.
Net loss for Q1 2025 totaled $93.0 million, or $0.53 per share.
Adjusted EBITDA decreased 8% to $58.1 million in Q1 2025.
Integrated Care segment revenue increased 3%, while BetterHelp segment revenue decreased 11%.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Outlook is based on current market conditions and expectations, includes anticipated contribution from the acquisition of UpLift.
Challenges Ahead
- Guidance does not include any impact from new tariff actions in 2025 due to continued uncertainty regarding implementation dates and scope of potential U.S. import tariffs or retaliatory tariffs.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...